Effects of sevelamer hydrochloride on mortality, lipid abnormality and arterial stiffness in hemodialyzed patients: a propensity-matched observational study

Evidence-based statin prescription for cardiovascular protection in renal impairment

(2011) Fabio Fabbian et al.   Clinical and Experimental Nephrology

Timing of Erythropoiesis-Stimulating Agent Initiation and Adverse Outcomes in Nondialysis CKD: a Propensity-Matched Observational Study

(2010) S. Seliger et al.   Clinical Journal of the American Society of Nephrology

Sevelamer and the bone–vascular axis in chronic kidney disease: bone turnover, inflammation, and calcification regulation

(2009) Vincent M. Brandenburg et al.   KIDNEY INTERNATIONAL

Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis

(2009) Bengt C. Fellström et al.   NEW ENGLAND JOURNAL OF MEDICINE

A 1-Year Randomized Trial of Calcium Acetate Versus Sevelamer on Progression of Coronary Artery Calcification in Hemodialysis Patients With Comparable Lipid Control: The Calcium Acetate Renagel Evaluation-2 (CARE-2) Study

(2008) Wajeh Qunibi et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)

(2008) Francesca Tentori et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study

(2008) F. Tentori et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Phosphate Binder Impact on Bone Remodeling and Coronary Calcification – Results from the BRiC Study

(2008) Daniela Veit Barreto et al.   NEPHRON CLINICAL PRACTICE